In this issue of Blood Transfusion, Manuel Muñoz and colleagues published a retrospective, matched cohort cost-analysis study on post-operative intravenous iron therapy in elective total lower limb arthroplasty…
The early clinical promise of percutaneous heart valve technology-a group of minimally invasive devices designed to treat cardiac valve dysfunction without the need for cardiopulmonary bypass-could one day play a prominent role in curbing the costs associated with treating heart failure, which is the current number-one driver of hospitalization among Medicare patients.
